PillsPharmac
  • Home
Successful Search?
Try one of the below options to narrow down your search.
Google Custom Search:
Loading
PHARMAC Search:

Documents may be browsed by date, eg; Today, May, 2013.

Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...

Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013

Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.

Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.

Remember to group or statements with parentheses if they are beside and statements.

Search examples

consultation
Search for consultations
media and not antibiotics
Search for media related documents that don't mention antibiotics.
(media or consultation) and vaccines
Search for media releases and consultation documents mentioning vaccinations.

Search term:

2003

PHARMAC documents that matched your search:

Prev, Next – Page 2 of 20 (193 documents)

icon

InPHARMation, December 2003 (2 pages, 75 KB)
2003/12/10
inpharmation

This year will see New Zealanders pay for about $566 million worth of prescription medicines, some 10 percent more than in 2002-03. We’re pleased that DHBs have agreed to allocate additional funding to pharmaceuticals, partly in recognition of the greater volume of medicines that will result from people gaining access to Primary Healthcare Organisations.

text


icon

Janssen-Cilag proposal regarding tacrolimus (Prograf) (2 pages, 468 KB)
2003/12/04
consultation, archive

text


icon

Janssen-Cilag proposal regarding tacrolimus (Prograf) (2 pages, 468 KB)
2003/12/04
consultation, archive

text


icon

PHARMAC welcomes new Board appointment (1 page, 36 KB)
2003/12/04
media, archive

PHARMAC Board chairman Richard Waddel has welcomed the appointment of Tauranga management consultant Adrienne von Tunzelmann to the Board of the Government drug- funding agency.

text


icon

Roche proposal regarding pegylated interferon alpha-2a (Pegasys) (3 pages, 880 KB)
2003/12/04
consultation, archive

And various other pharmaceuticals.

text


icon

Roche proposal regarding pegylated interferon alpha-2a (Pegasys) (3 pages, 880 KB)
2003/12/04
consultation, archive

And various other pharmaceuticals.

text


icon

Annual Review 2002/03 - Highlights (1 page, 35 KB)
2003/11/27
media, archive

Providing new or expanded access to 10 subsidised treatments, including those for chronic myeloid leukaemia, anaemia associated with kidney failure, breast cancer, heavy menstrual bleeding and osteoporosis. Containing community pharmaceutical expenditure growth by successfully negotiating savings worth approximately $50.3 million.

text


icon

Big jump in statins use but many still not accessing (2 pages, 38 KB)
2003/11/27
media, archive

More people are getting the benefits of cholesterol-lowering statin drugs but prescribing figures could be higher yet, says PHARMAC Medical Director, Dr Peter Moodie. Figures just released in PHARMAC’s 2003 Annual Review show a massive 65 percent leap in statins prescribing, with about 140,000 people now receiving the medicines.

text


icon

Declining applications for listing of various acetylcholinesterase inhibitors (1 page, 191 KB)
2003/11/27
consultation, archive

text


icon

Medicine use continues to rise (2 pages, 37 KB)
2003/11/27
media, archive

New Zealanders are taking more medicine than ever before, according to figures just released by drug funding agency PHARMAC. In the year to June 2003, New Zealand patients were written some 22.4 million prescriptions for subsidised medicine (accounting for about two-thirds of all prescribed medicines by value).

text


Prev, Next – Page 2 of 20 (193 documents)

New Zealand GovernmentAbout Us | Contact Us